XWELL Comments on CPC’s Withdrawal of Threatened Proxy Fight and Related Lawsuit
August 13 2024 - 4:00PM
XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority
in wellness solutions for people on the go, today issued the
following statement in response to CPC Pain & Wellness SPV,
LLC’s (“CPC”) decision to withdraw its threatened proxy fight and
related lawsuit against XWELL, in connection with the Company’s
2024 annual meeting of stockholders (the “2024 Annual Meeting”).
Bruce Bernstein, Chairman of the Board stated,
“We are pleased that CPC decided to withdraw its threatened proxy
fight and lawsuit against XWELL related to our 2024 Annual Meeting.
Looking ahead, we are fully focused on delivering on our strategic
plan to drive durable, long-term value creation for stockholders.
We are appreciative of the constructive engagement we’ve had with
stockholders to-date and look forward to continued engagement with
them leading up to XWELL’s 2024 Annual Meeting.”
About XWELL, Inc.
XWELL, Inc. (Nasdaq: XWEL) is a leading
global wellness holding company operating multiple
brands: XpresSpa®, Treat™, Naples Wax Center®,
XpresCheck® and HyperPointe™.
- XpresSpa is a leading retailer
of wellness services and related products, with 33 locations in 16
airports globally.
- Naples Wax Center is a group of
upscale skin care boutiques, with three locations currently
operating.
- XpresCheck is a provider of
screening and diagnostic testing in partnership with the CDC and
Concentric by Ginkgo, conducting bio surveillance monitoring in its
airport locations to identify new SARS-CoV-2 variants of interest
and concern as well as other pathogens entering the country from
across the world.
- HyperPointe is a leading digital
healthcare and data analytics relationship company serving the
global healthcare industry.
Contacts
Longacre Square PartnersJessica McDougall /
Christina Spellman, (646) 386-0091XWELL@longacresquare.com
Forward Looking Statements
This press release may contain “forward-looking”
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words “believes,” “expects,” “anticipates,”
“estimates,” “projects,” “intends,” “should,” “seeks,” "future,”
“continue,” or the negative of such terms, or other comparable
terminology. Forward-looking statements relating to expectations
about future results or events are based upon information available
to XWELL as of today's date and are not guarantees of the future
performance of the Company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in the Company’s
Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and
Current Reports on Form 8-K, and other SEC filings (which
reports were filed under the Company’s former name, XpresSpa Group,
Inc., prior to its previously announced name change
effective October 25, 2022). All subsequent written and oral
forward-looking statements concerning XWELL, or other matters and
attributable to XWELL or any person acting on its behalf are
expressly qualified in their entirety by the cautionary statements
above. XWELL does not undertake any obligation to publicly update
any of these forward-looking statements to reflect events or
circumstances that may arise after the date hereof.
Important Additional
Information
The Company intends to file a definitive proxy
statement and a WHITE Proxy Card with
the U.S. Securities and Exchange Commission (the “SEC”) in
connection with the 2024 Annual Meeting. STOCKHOLDERS
OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH PROXY
STATEMENT,
ACCOMPANYING WHITE PROXY
CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN
THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN
IMPORTANT INFORMATION ABOUT THE 2024 ANNUAL
MEETING. Stockholders will be able to obtain the
definitive proxy statement, any amendments or supplements to the
proxy statement and other documents filed by the Company with the
SEC at no charge at the SEC’s website at www.sec.gov. Copies will
also be available at no charge at the Company’s website
at https://www.xwell.com/sec-filings.
Participant Information
The Company, its directors and certain of its
executive officers are “participants” (as defined in Section 14(a)
of the Securities Exchange Act of 1934, as amended) in the
solicitation of proxies from the Company’s stockholders in
connection with the matters to be considered at the 2024 Annual
Meeting. Information about the compensation of our named executive
officers and our non-employee directors is set forth in the
sections entitled “Compensation” and “Director Compensation” in the
Company’s preliminary proxy statement, filed on August 2, 2024 (the
“Preliminary Proxy Statement”), commencing on pages 23 and 25,
respectively, and available here. Information regarding the
participants’ holdings of the Company’s securities can be found in
the section entitled “Security Ownership of Certain Beneficial
Owners and Management” in the Preliminary Proxy Statement on page
31 and available here. If any filings are made by the Company
with the SEC on Forms 3, 4, and 5 with respect to the participants’
holdings of the Company’s securities, the Company will provide
updates and such filings will be available on the Company’s website
at https://www.xwell.com/sec-filings or through the SEC’s
website at www.sec.gov. Updated information regarding the
identity of potential participants, and their direct or indirect
interests, by security holdings or otherwise, will be set forth in
the section entitled “Security Ownership of Certain Beneficial
Owners and Management” of the Company’s definitive proxy statement
on Schedule 14A and other materials to be filed with the SEC.
XWELL (NASDAQ:XWEL)
Historical Stock Chart
From Nov 2024 to Dec 2024
XWELL (NASDAQ:XWEL)
Historical Stock Chart
From Dec 2023 to Dec 2024